Johnson & Johnson (JNJ)

In the past 90 days, there have been no insider trading transactions reported for Johnson & Johnson, with a total count of zero and no net value associated with any trades. The company's stock has experienced a price decline of 3.5% over this period. The last earnings report, dated April 15, 2025, indicated an earnings per share (EPS) beat of approximately 6.95%. The next earnings report is scheduled for July 16, 2025.

Track

Stock chart
Ticker: JNJ Exchange: NYS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-26 2025-02-25 S Sale

Decker Robert J

VP Corporate Controller

Officer
6,999 -25.0%
165.88
USD 1,160,994 		6,999 -25.0% 165.88 USD 1,160,994
2025-02-18 2025-02-18 S Sale

Schmid Timothy

EVP, WW Chair, MedTech

Officer
403 -2.6%
156.15
USD 62,928 		403 -2.6% 156.15 USD 62,928
2025-02-11 2025-02-07 S Sale

Wolk Joseph J

Exec VP, CFO

Officer
13,015 -100.0%
153.89
USD 2,002,878 		13,015 -100.0% 153.89 USD 2,002,878
2024-12-12 2024-12-12 B Purchase

WEINBERGER MARK A

Non-Executive Director
1,000 +inf%
147.22
USD 147,220 		1,000 +inf% 147.22 USD 147,220
2024-09-03 2024-08-30 S Sale

Decker Robert J

VP Corporate Controller

Officer
5,635 -22.9%
165.06
USD 930,113 		5,635 -22.9% 165.06 USD 930,113
2024-03-13 2024-03-13 S Sale

Broadhurst Vanessa

EVP, Global Corp Affairs

Officer
8,891 -37.1%
162.16
USD 1,441,765 		8,891 -37.1% 162.16 USD 1,441,765
2024-02-12 2024-02-09 S Sale

Taubert Jennifer L

EVP, WW Chair, Pharmaceuticals

Officer
59,397 -29.6%
156.27
USD 9,281,969 		59,397 -29.6% 156.27 USD 9,281,969
2023-07-27 2023-07-26 S Sale

Hait William

See Remarks

Officer
14,698 -14.3%
172.00
USD 2,528,056 		14,698 -14.3% 172.00 USD 2,528,056
2023-07-27 2023-07-25 S Sale

Fasolo Peter

Exec VP, Chief HR Officer

Officer
20,000 -16.3%
170.32
USD 3,406,498 		20,000 -16.3% 170.32 USD 3,406,498
2023-06-14 2023-06-12 S Sale

Wengel Kathryn E

EVP, Chief TO and Risk Officer

Officer
12,465 -15.9%
160.00
USD 1,994,400 		12,465 -15.9% 160.00 USD 1,994,400
2023-03-08 2023-03-06 S Sale

Swanson James D.

See Remarks

Officer
1,062 -10.3%
154.66
USD 164,199 		1,062 -10.3% 154.66 USD 164,199
2022-12-15 2022-12-13 S Sale

Wolk Joseph J

Exec VP, CFO

Officer
12,926 -26.5%
179.62
USD 2,321,755 		12,926 -26.5% 179.62 USD 2,321,755
2022-12-15 2022-12-13 S Sale

Wolk Joseph J

Exec VP, CFO

Officer
1,855 -3.7%
179.46
USD 332,906 		1,855 -3.7% 179.46 USD 332,906
2022-12-02 2022-11-30 S Sale

McEvoy Ashley

EVP, WW Chair, MedTech

Officer
71,923 -63.2%
175.46
USD 12,619,272 		71,923 -63.2% 175.46 USD 12,619,272
2022-12-02 2022-11-30 S Sale

McEvoy Ashley

EVP, WW Chair, MedTech

Officer
1,400 -1.2%
176.09
USD 246,529 		1,400 -1.2% 176.09 USD 246,529
2022-11-23 2022-11-22 S Sale

Taubert Jennifer L

EVP, WW Chair, Pharmaceuticals

Officer
76,923 -37.8%
176.78
USD 13,598,402 		76,923 -37.8% 176.78 USD 13,598,402
2022-11-21 2022-11-18 S Sale

Decker Robert J

Controller, CAO

Officer
16,928 -52.2%
175.00
USD 2,962,400 		16,928 -52.2% 175.00 USD 2,962,400
2022-11-10 2022-11-09 S Sale

Wengel Kathryn E

EVP, Chief GSC Officer

Officer
16,410 -18.7%
173.42
USD 2,845,773 		16,410 -18.7% 173.42 USD 2,845,773
2022-11-08 2022-11-04 S Sale

Mongon Thibaut

Exec VP, WW Chair, Consumer

Officer
18,293 -31.3%
171.22
USD 3,132,036 		18,293 -31.3% 171.22 USD 3,132,036
2022-11-08 2022-11-04 S Sale

Mongon Thibaut

Exec VP, WW Chair, Consumer

Officer
16,953 -22.5%
171.14
USD 2,901,269 		16,953 -22.5% 171.14 USD 2,901,269
// ... existing code ...